Remotiv (Ze 117) is a tablet containing 250 mg of Hypericum perforatum (St John’s Wort) extract, standardised to 500 mcg hypericin.
It is manufactured in Switzerland by Zeller, a herbal medicine company with 135 years of involvement in the research and production of natural medicines. More than 500 million Remotiv tablets have been sold worldwide, equivalent to 6 million treated patients.
Remotiv is used in the treatment of:
The safety and efficacy of Remotiv have been confirmed by a number of controlled clinical trials, compared with either placebo, or well established synthetic antidepressant medicines:
Results of the clinical studies have been published in reputable medical journals.
Remotiv has no negative effects when taken concurrently with the contraceptive pill.
Sexual dysfunction, frequently experienced by patients taking synthetic antidepressants, does nor occur with Remotiv therapy.
The adult dose of Remotiv is 1 tablet twice daily, to be taken morning and evening. The normal duration of treatment is four to six weeks.
Unless advised by a health care professional, Remotiv should not be taken during pregnancy or by breastfeeding mothers, due to lack of clinical evidence in these patient groups.
Always read the label. Use only as directed. If symptoms persist, patients should consult their health care professional.